Who is the CEO of COLL? | Glauxie AI

Q: Who is the CEO of COLL?

Collegium Pharmaceutical, Inc. (COLL) operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector). The company is led by CEO Vikram Karnani. Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release,... Employees: 423.

Q: What does COLL company do?

Learn what COLL does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling COLL?

Track recent insider buys and sells for COLL with transaction details, amounts, and trends.

Q: What sector is COLL in?

Find COLL sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of COLL?

🦉

Collegium Pharmaceutical, Inc. (COLL)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - Specialty & Generic

CEOVikram Karnani

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and...

Key Executives

Name	Title
Colleen Tupper	Executive Vice President & Chief Financial Officer
David Dieter	Executive Vice President, General Counsel & Corporate Secretary
Dean J. Patras	Chief People Officer
Ian Karp	Head of Investor Relations
Jane Gonnerman	Executive Vice President of Strategy & Corporate Development
Jessica Cotrone	Senior Vice President of Communications & Corporate Affairs

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

COLL Profile Financials

What does COLL company do? Are insiders buying or selling COLL? What sector is COLL in?